As the medical paradigm shifts from treatment-centered approaches to disease prevention care,  
the importance of diagnosis is continuously being emphasized. 
Healthy life begins with an accurate diagnosis.  
We pursue the health of all living creatures through diagnosis based on our advanced technology.
                       Bionote is a specialized company of the in-vitro diagnostics with international branches across the  
                           United States and China - the leading  countries of the diagnostic field. 
                           Along with our BL-3 research facility, we possess superior technology in  recombinant 
 
                           antigen manufacturing and are expanding our business  scope by entering a highly valued market of the bio reagent industry.
                       With our advanced technology and vigorous product development, Bionote could become  
                            the company it is today - a global in-vitro diagnostic leader. 
From Point-of-Care 
                            screening tests to confirmatory tests, Bionote offers a wide portfolio of  IVD products.  
                            Bionote aims to provide a total diagnostic portfolio for all living creatures alike,  
                            with a vision  to make  the world a better place for both humans and animals.
                            
                    Bionote is an innovative leader in charge of the animal health industry from A to Z.
                           
                           
                           
                           
                           ※Initial disease screening to confirmatory tests based on the core technology